ADMA ADMA Corp: Net earnings per share for the last 12 months

Public company logo of ADMA Biologics Inc (ADMA)

ADMA Biologics dominates the plasma-replacement segment through patents and raw material shortages. Its own facility in Florida guarantees supply stability. The annual percentage change in EPS TTM confirms the model's efficiency, where -10.30 shows the value of this parameter. Growth is supported by strategic partnerships with blood collection centers and joint research with immunological institutes.

ADMA ADMA Biologics Inc Earnings per share for the last twelve months (02/11/2024 - 11/15/2026)

ADMA Corp - analytical breakdowns and key metrics (ADMA)

- market value and analyst target forecast:
Stock Quotes ADMA Biologics Inc|ADMA - Price Target Chart
- company stock capitalization data:
Market Valuation ADMA Biologics|ADMA - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share ADMA Biologics|ADMA - Company Book Value|Capitalization to Book Value Ratio admabiologics.com|ADMA - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital ADMA Biologics|ADMA - Long-Term Debt to Capital|Short-Term Debt to Capital ADMA Biologics|ADMA - Company Aggregate Debts|Debt to Book Value Ratio ADMA Corp|ADMA - Company Long-Term Debt|Company Current Liabilities ADMA Biologics|Quick Ratio admabiologics.com
- earnings and multiples data:
ADMA - Net Income|Expected Net Income ADMA Biologics|ADMA - P/E Multiple|Future Price to Earnings ADMA Bio|ADMA - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio ADMA Corp|ADMA - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months ADMA Biologics|ADMA - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months admabiologics.com|ADMA - Earnings per share growth in current year|Expected net earnings per share growth next year ADMA Biologics
- revenue and sales details:
ADMA - Revenue and Sales Volume|Company Sales Forecast ADMA Biologics, Inc.|ADMA - P/S Multiple|Market Cap to Expected Sales Ratio ADMA Bio|ADMA - Sales Growth YoY (TTM)
Fundamental company valuation:ADMA Biologics Inc, ADMA
Core merchandise of ADMA Bio

High barriers to entry in the plasma replacement sector, driven by stringent FDA oversight, provide ADMA Biologics (ADMA) with a sustainable competitive advantage. By analyzing the YoY TTM change in net income per share, an investor assesses the business's ability to scale revenue faster than cost inflation, where outperforming industry-average growth rates confirms efficient capital management and the high market value of protected assets.

Competitor analysis

argenx N.V. (ARGX) - Net earnings per share for the last 12 months|BioNTech Pharma (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) immunovant.com|Earnings per share for the last twelve months Kiniksa Pharmaceuticals Ltd (KNSA)|Grifols - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (adaptivebiotech.com)|Celldex (CLDX) - Net earnings per one share for the last twelve months|Aurinia Corp - Net earnings per share (EPS TTM)|BCRX: Earnings per share for the last twelve months|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|PHVS (Pharvaris NV) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AbCellera Corp (ABCL)|Earnings per share for the last twelve months Tourmaline Bio, Inc. (TRML)|Net earnings per share for the last 12 months Precigen, Inc. PGEN|Earnings per share for the last twelve months Pharming Group NV PHAR|Net earnings per share (EPS TTM) Nektar Therapeutics Inc NKTR|Upstream Bio, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ZBIO (Zenas Biopharma, Inc.)|immunome.com (IMNM) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months gossamerbio.com (GOSS)|KALV (kalvista.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Septerna Corp|Net earnings per share (EPS TTM) PVLA|Savara Corp - Earnings per share for the last 12 months|Earnings per share for the last twelve months Rigel Pharmaceuticals RIGL|AnaptysBio (ANAB) - Net earnings per one share for the last twelve months|ATXS - Earnings per share for the last twelve months|ENGN (enGene) - Earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aerovate (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) kyvernatx.com|Earnings per share for the last twelve months Tiziana Life Sciences Ltd. (TLSA)|CABA (Cabaletta Bio) - Earnings per share for the trailing year|Earnings per share for the last twelve months Ventyx Biosciences VTYX|Net earnings per share for the last four quarters Theratechnologies Inc (THTX)|avalotx.com - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|AGEN (Agenus Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Climb Bio Inc.|Net earnings per share for the last 12 months ZURA|ATYR (aTyr Pharma, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ImageneBio (IMA)|Shattuck Labs - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) equilliumbio.com EQ|connectbiopharm.com - Net earnings per share (EPS TTM)|immunic-therapeutics.com (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx N.V. (IFRX) - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months x4pharma.com XFOR|Net earnings per share for the last 12 months adicetbio.com (ACET)|Earnings per share for the last twelve months Celularity Inc (CELU)|Net earnings per share for the last 12 months INmune Bio Corp INMB|Earnings per share for the last twelve months barinthusbio.com BRNS|Earnings per share for the trailing year KZR|sabbiotherapeutics.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AKTX (Akari Therapeutics PLC)|ENLV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months QTTB|GOVX (geovax.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech|Net earnings per share (EPS TTM) IBIO|Net earnings per share for the last 12 months Carisma Therapeutics Inc. CARM|Earnings per share for the last twelve months XTL Biopharmaceuticals, Ltd. XTLB|Net earnings per share (EPS TTM) boltbio.com BOLT|HCWB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. (AIM) - Earnings per share for the last twelve months|ADTX: Earnings per share for the last four quarters|GRI (GRI Bio Corporation) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) XORTX Therapeutics Inc.|Earnings per share for the last twelve months Vyome Holdings (HIND)|Net earnings per share for the last four quarters revbiosciences.com|Earnings per share for the last twelve months Indaptus Therapeutics Inc INDP|Net earnings per share (EPS TTM) Scinai SCNI|CALI - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AFMD|ALLK (Allakos Therapeutics) - Net earnings per share for the last 12 months|HOOKIPA - Earnings per share for the trailing year|IGMS (IGM Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iTeos Therapeutics Inc ITOS|Earnings per share for the last twelve months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TC Biopharm TCBP|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc.)